Hem › Bröstcancer › Connecticut › Bridgeport
Kliniska studier för Bröstcancer i Bridgeport, CT
21 studier för Bröstcancer söker deltagare vid platser i och runt Bridgeport (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- Stony Brook University Medical Center, Stony Brook · 18 mi bort
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekryterarFas 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · 18 mi bort
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekryterarFas 3
- Research Site, Stony Brook · 18 mi bort
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekryterarFas 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 4 mi bort
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · 5 mi bort
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Rekryterar
- Stony Brook Cancer Center, Stony Brook · 18 mi bort
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
RekryterarFas 1/2
- Stony Brook University Hospital, Stony Brook · 18 mi bort
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekryterarFas 3
- Stony Brook University Medical Center, Stony Brook · 18 mi bort
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekryterarFas 3
- Stony Brook University Cancer Center, Stony Brook · 18 mi bort
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekryterarFas 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · 19 mi bort
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · 19 mi bort
- New York Cancers & Blood Specialists, Port Jefferson Station · 19 mi bort
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekryterarFas 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi bort
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi bort
- och 1 fler
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
RekryterarFas 2
- Stony Brook Cancer Center, Stony Brook · 18 mi bort
ATEMPT 2.0: Adjuvant T-DM1 vs TH
RekryterarFas 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · 4 mi bort
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · 5 mi bort
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
RekryterarFas 1
- New York Cancer and Blood Specialists, Port Jefferson Station · 19 mi bort
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekryterarFas 3
- Stony Brook University Cancer Center, Stony Brook · 18 mi bort
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekryterarFas 3
- Smilow Cancer Hospital - Fairfield, Fairfield · 5 mi bort
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekryterarFas 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi bort
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi bort
- Stony Brook University Medical Center, Stony Brook · 18 mi bort
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekryterarObservationsstudie
- Stony Brook Medicine, Stony Brook · 18 mi bort
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
RekryterarTidig fas 1
- Stony Brook Breast Center, Stony Brook · 18 mi bort
Definitive Radiation Therapy for Inoperable Breast Cancer
Rekryterar
- Stony Brook University Cancer Center, Stony Brook · 18 mi bort
Definitive Radiation for High-Risk Spine Metastases
RekryterarFas 2
- Stony Brook University Hospital, Stony Brook · 18 mi bort
CtDNA Based MRD Testing for NAC Monitoring in TNBC
RekryterarObservationsstudie
- Stony Brook University Cancer Center, Stony Brook · 18 mi bort
Bröstcancer-studier i andra städer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andra studier i Bridgeport
- Icke-småcellig lungcancer14 studier
- Lungcancer13 studier
- Akut myeloid leukemi12 studier
- Hjärt-kärlsjukdom9 studier
- Cancer (alla typer)8 studier
- Plattenepitelcancer i huvud och hals8 studier
- Metastaserande cancer7 studier
- Hjärtsvikt7 studier
- Hjärnaneurysm6 studier
- Multipelt myelom6 studier
- Prostatacancer6 studier
- Äggstockscancer5 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.